Volition Veterinary used our video to illustrate this Key Opinion Leader event
To see the video click here
Volition Veterinary also presented two abstracts relating to its first product, the Nu.Q™ Vet Cancer Screening Test, at the 2020 Veterinary Cancer Society (VCS) Virtual Annual Conference.
The first abstract was “Characterizing Circulating Nucleosomes in the Plasma of Dogs with Lymphoma,” and the second abstract, dealt with “Characterizing Circulating Nucleosomes in the Plasma of Dogs with Hemangiosarcoma”.
Volition is proud to sponsor the 2020 VCS Virtual Annual Conference and will be providing more information about the veterinary applications of its Nucleosomics™ technology for early detection of cancer and other diseases from a virtual exhibition booth at the event.